• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDOS INTERNATIONAL SARL EU 4.5X37MM STENT 12 MM DW TIP; INTRACRANIAL NEUROVASCULAR STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDOS INTERNATIONAL SARL EU 4.5X37MM STENT 12 MM DW TIP; INTRACRANIAL NEUROVASCULAR STENT Back to Search Results
Catalog Number ENC453712
Device Problems Premature Activation (1484); Difficult to Remove (1528); Activation Problem (4042)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 05/12/2022
Event Type  malfunction  
Event Description
As reported by the field, during a stent assist coil embolization, a 4.5x37mm enterprise stent 12 mm dw tip (enc453712, 6920548) became impeded in an unspecified microcatheter (mc) and released outside of the patient¿s body.It was reported that during procedure, stent arrived in parent artery and released the distal end of the stent for about 5mm.The physician observed that the position of the stent was not appropriate, then he tried to retract it for adjusting, but felt some resistance.The stent was retracted into the microcatheter after several attempts.The doctor tried to release the stent again, but still felt resistance.The stent could not be released completely (could only release the distal end of the stent for about 2mm).The stent was withdrawn and found to be released on operation table.A new stent was used to complete the surgery.There was no patient injury report.
 
Manufacturer Narrative
Product complaint # (b)(4).Information regarding patient weight, height, medical history, race, and ethnicity was not reported.Initial reporter phone: (b)(6).The device is available to be returned for evaluation and testing.However, it has not been received to date as indicated as ¿other¿ as the reason for non-evaluation.If the device returns, a device investigation will be performed.A supplemental report will be submitted if new facts arise which materially alter information submitted in a previous mdr report.Missing information from this report is identified as blank; this information was not provided in the reported event or available at the time of report submission.The company is seeking this information through the event investigation.This report is being submitted pursuant to the provisions of 21 cfr, part 4.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by cerenovus, or its employees that the report constitutes an admission that the product, cerenovus, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
 
Manufacturer Narrative
Product complaint #(b)(4).Section b5: additional information received indicated that no additional intervention was needed to remove the device from the patient.No excessive force was applied to the device.The system was used with the recommended microcatheter.They were able to torque the device.There was no evidence of physical material within the device.It was necessary to remove the mc with the enterprise.The target site being treated was the left middle cerebral artery.It was noted that the vessel was curved.There were no procedural delays due to the event.A supplemental report will be submitted if new facts arise which materially alter information submitted in a previous mdr report.This is one of two products involved with the complaint and the associated manufacturer report numbers are 3008114965-2022-00388 and 3008114965-2022-00525.
 
Manufacturer Narrative
Product complaint #
=
> pc-001124122 updated sections on this medwatch: b4, d9, g3, g6, h2, h3, h6 and h10.A supplemental report will be submitted if new facts arise which materially alter information submitted in a previous mdr report.Complaint conclusion: as reported by the field, during a stent assist coil embolization, a 4.5x37mm enterprise stent 12 mm dw tip (enc453712, 6920548) became impeded in a 150/5cm prowler select plus microcatheter (606s255x , 30686635 ) and released outside of the patient¿s body.It was reported that during the procedure, the stent arrived in the parent artery and released the distal end of the stent for about 5mm.The physician observed that the position of the stent was not appropriate, then he tried to retract it for adjusting, but felt some resistance.The stent was retracted into the microcatheter after several attempts.The doctor tried to release the stent again, but still felt resistance.The stent could not be released completely (could only release the distal end of the stent for about 2mm).The stent was withdrawn and found to be released on the operation table.A new stent was used to complete the surgery.There was no patient injury report.A non-sterile eu 4.5x37mm stent 12 mm dw tip was received contained in the decontamination pouch.Upon receiving the device, visual inspection was performed, the stent was already detached from the unit, then it was inspected, and no abnormalities were found on it (i.E.No broken struts, no kinks).The delivery wire was also inspected, and it was found in good condition.The introducer was not returned for evaluation.The functional analysis could not be performed due to the stent was returned already detached from the unit.The stent must be still inside the introducer tube to perform the functional analysis.A device history record (dhr) was performed, and it indicated this product was final inspection tested at lake region medical and was determined to be acceptable.Due to the condition in which the device was received (stent was returned already detached from the unit), the customer complaint delivery wire, withdrawal difficulty-from vessel was not able to be evaluated, however, no damages were found in the device that contribute to the reported event, procedural factors may contribute to the device failure.The customer complaint regarding partial deployment of the stent could not be confirmed since in the inspection of the stent no damages were found on it, also no other abnormalities were found on the device that contribute to the complaint.It is possible that clinical and procedural factors, including device manipulation and vessel characteristics, may have contributed to the reported failure.The stent was received fully deployed, due to this condition the customer complaint regarding a premature deployment of the stent was able to be confirmed.A device history record evaluation was performed, and no non-conformances were identified.As part of the cerenovus quality process, all devices are manufactured, inspected, and released to it should be noted that product failure could be caused by multiple factors.The instructions for use (ifu) do contain the following recommendations: ¿ do not apply undue force if resistance is encountered at any point during stent manipulation.Withdraw the unit and advance to a new one.¿ if resistance is felt while recapturing the stent, do not continue to recapture the device.Withdraw the infusion catheter slightly to unsheathe the stent (without exceeding the recapture limit), and then attempt to recapture the stent again.Assignment of root cause for the events remains speculative and inconclusive, based on the limited information provided and the evidence presented by the returned device; however, it is possible that clinical and procedural factors, including device manipulation and device interaction, may have contributed to the reported failures and damages on the returned system.As part of the cerenovus quality process, all devices are manufactured, inspected, and released to approved specifications.As part of the post market surveillance program, information from this complaint is trended to identify statistical signals for consideration of further correction action.Since there was no evidence to suggest the event was related to a manufacturing or design issue, no corrective actions will be taken at this time.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EU 4.5X37MM STENT 12 MM DW TIP
Type of Device
INTRACRANIAL NEUROVASCULAR STENT
Manufacturer (Section D)
MEDOS INTERNATIONAL SARL
chemin-blanc 38
le locle neuchatel CH-24 00
SZ  CH-2400
Manufacturer (Section G)
CODMAN AND SHURTLEFF, INC
325 paramount dr
raynham MA 02767
Manufacturer Contact
michelleann garcia
31 technology dr
irvine, CA 92618
646591-798
MDR Report Key14547554
MDR Text Key300792273
Report Number3008114965-2022-00388
Device Sequence Number1
Product Code NJE
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
H60001
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup
Report Date 08/08/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/31/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/28/2023
Device Catalogue NumberENC453712
Device Lot Number6920548
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Date Manufacturer Received08/04/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured12/22/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
UNSPECIFIED MICROCATHETER
-
-